U.S. CMO/CDMO Market Trends, Size, Share, and Growth Forecast, 2025 - 2032

Table of Content

1. Executive Summary
   1. U.S. CMO/CDMO Market Snapshot, 2025 and 2032
   2. Market Opportunity Assessment, 2025 - 2032, US$ Bn
   3. Key Market Trends
   4. Future Market Projections
   5. Premium Market Insights
   6. Industry Developments and Key Market Events
   7. PMR Analysis and Recommendations
2. Market Overview
   1. Market Scope and Definition
   2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Key Trends
   3. Macro-Economic Factors
      1. U.S. Sectorial Outlook
      2. U.S. GDP Growth Outlook
   4. COVID-19 Impact Analysis
   5. Forecast Factors - Relevance and Impact
3. Value Added Insights
   1. Service Adoption Analysis
   2. Regulatory Landscape
   3. List of Service Providers
   4. Value Chain Analysis
   5. Key Deals and Mergers
   6. PESTLE Analysis
4. U.S. CMO/CDMO Market Outlook:
   1. Key Highlights
      1. Market Size (US$ Bn) and Y-o-Y Growth
      2. Absolute $ Opportunity
   2. Market Size (US$ Bn) Analysis and Forecast
      1. Historical Market Size (US$ Bn) Analysis, 2019-2024
      2. Market Size (US$ Bn) Analysis and Forecast, 2025-2032
   3. U.S. CMO/CDMO Market Outlook: Source
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Service, 2019-2024
      3. Market Size (US$ Bn) Analysis and Forecast, By Service, 2025-2032
         1. Drug Discovery and Development
         2. API Manufacturing
         3. Finished Dosage Formulation Development
         4. Packaging/Distribution
      4. Market Attractiveness Analysis: Service
   4. U.S. CMO/CDMO Market Outlook: Scale of Operation
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Scale of Operation, 2019-2024
      3. Market Size (US$ Bn) Analysis and Forecast, By Scale of Operation, 2025-2032
         1. Preclinical
         2. Clinical
         3. Commercial
      4. Market Attractiveness Analysis: Scale of Operation
   5. U.S. CMO/CDMO Market Outlook: Organization Size
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Organization Size, 2019-2024
      3. Market Size (US$ Bn) Analysis and Forecast, By Organization Size, 2025-2032
         1. Small-sized
         2. Mid-sized
         3. Large-sized
      4. Market Attractiveness Analysis: Organization Size
   6. U.S. CMO/CDMO Market Outlook: Therapeutic Area
      1. Introduction/Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Therapeutic Area, 2019-2024
      3. Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area, 2025-2032
         1. Infectious Diseases
         2. Oncology
         3. CNS
         4. Cardiovascular
         5. Respiratory
         6. Others
      4. Market Attractiveness Analysis: Therapeutic Area
5. Competition Landscape
   1. Market Share Analysis, 2024
   2. Market Structure
      1. Competition Intensity Mapping By Market
      2. Competition Dashboard
   3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
      1.  Thermo Fisher Scientific Inc.
         1. Overview
         2. Segments and Service Types
         3. Key Financials
         4. Market Developments
         5. Market Strategy
      2. AGC Biologics
      3. Curia Global, Inc.
      4. LGM Pharma
      5. Cell Culture Company, LLC
      6. Ascendia Pharmaceutical Solutions
      7. Kindeva
      8. Crystal Pharmatech Co., Ltd.
      9. Asymchem Inc.
      10. Pharmaceutics International, Inc
      11. Catalent, Inc
      12. Cambrex Corporation
      13. CARBOGEN AMCIS
      14. Lonza
      15. Bora Pharmaceuticals
      16. BioSpring
      17. Quotient Sciences
      18. Hillgene Biopharma Co., Ltd.
      19. CMIC HOLDINGS Co., LTD.
      20. Evonik
      21. Novartis AG
      22. Piramal Pharma Limited
      23. CordenPharma
      24. Recipharm AB.
6. Appendix
   1. Research Methodology
   2. Research Assumptions
   3. Acronyms and Abbreviations